Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 4.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 17.60p
  • 52 Week Low: 1.50p
  • Currency: UK Pounds
  • Shares Issued: 623.91m
  • Volume: 21,262
  • Market Cap: £24.96m
  • RiskGrade: 328
  • Beta: 0.01

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £59,538
Lisa Baderoon 583,963 £23,358
Tim Franklin 525,000 £21,000

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 112,236,910 £4,489,476
Invesco Ltd 17,872,341 £714,894
Aviva Investors Global 11,285,180 £451,407
Alora Pharmaceuticals LLC 10,909,091 £436,364
M&G Investments 7,600,000 £304,000
Prudential plc 7,600,000 £304,000
Capital Income Builder 4,870,367 £194,815
Dr R Zimmer 4,551,553 £182,062
Odey Asset Management 3,433,319 £137,333
Rhone Trustees (Switzerland) SA 3,386,000 £135,440
Pictet Overseas Trust Corporation Limited 3,287,500 £131,500

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 4.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 17.60p
52 Week Low 1.50p
Volume 21,262
Shares Issued 623.91m
Market Cap £24.96m
Beta 0.01
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 24-Jul-2026

Time Volume / Share Price
08:19 11,581 @ 4.30p
08:00 9,255 @ 4.30p
08:00 22 @ 4.50p
08:00 125 @ 4.50p
08:00 279 @ 3.90p

Immupharma Key Personnel

CFO Ashley Clarke

Top of Page